About Imugene Limited (IMU)
Imugene Limited is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Sydney, Australia. IMU has been publicly traded since 1993, giving it 33+ years of trading history.
Imugene Limited (IMU) has been publicly traded since 1993, making it a 33-year-old public company. It operates in the Biotechnology industry within the Healthcare sector. The company is headquartered in Sydney, Australia and employs approximately 15 people. With a market capitalization of A$60 million, IMU is a micro-cap company.
IMU trades on the Australian Securities Exchange and is classified as a micro-cap-cap stock with a market capitalization of approximately A$60 million. The company employs approximately 15 people worldwide.
Key Statistics
- Current Price
- A$0.19
- Market Cap
- A$60.08M
- 52-Week High
- A$1.39
- 52-Week Low
- A$0.18
- Sector
- Healthcare
- Industry
- Biotechnology
IMU Investment Performance
IMU has declined 49.3% year-to-date in 2026. Over the past 5 years, a A$1,000 investment in IMU would have grown to A$45, representing a -95.5% total return. Since its IPO in 1993, a A$1,000 investment would now be worth A$6.
A$1,000 Invested in Imugene Limited (IMU)
How much would A$1,000 invested in IMU be worth today?
What would A$1,000 invested in IMU 1 year ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2025 would be worth A$170 as of March 2026, representing a -83.0% total return.
What would A$1,000 invested in IMU 3 years ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2023 would be worth A$42 as of March 2026, representing a -95.8% total return.
What would A$1,000 invested in IMU 5 years ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2021 would be worth A$45 as of March 2026, representing a -95.5% total return.
What would A$1,000 invested in IMU 10 years ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2016 would be worth A$549 as of March 2026, representing a -45.1% total return.
What would A$1,000 invested in IMU at IPO be worth today?
A A$1,000 investment in Imugene Limited (IMU) at IPO would be worth A$6 as of March 2026, representing a -99.4% total return.
Monthly Returns Heatmap
Over the past 32+ years (387 months), Imugene Limited (IMU) has averaged a monthly return of +2.07% with a median return of -2.50%. The stock had 142 positive months (37%) and 202 negative months (52%). The best month in IMU's history was January 2002 with a +400.0% return, while the worst was February 2002 at -81.4%. Historically, July tends to be the strongest month (averaging +16.0%), and June the weakest (-8.2%).
IMU's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2002 with a cumulative return of +379.3%, and the worst was 2001 at -119.1%.
Annual Returns
Over 33 years of trading history, Imugene Limited (IMU) has delivered an average annual return of +7.96% with a median return of -19.79%. The compound annual growth rate (CAGR) is -14.27%. The stock posted gains in 14 years (42%) and losses in 19 years (58%).
IMU's best year was 2021 with a +300.00% gain, while the worst was 2011 at -78.18%. The longest streak of consecutive positive years was 4, and the longest losing streak was 5 years. IMU achieved double-digit gains (10%+) in 12 years. It suffered double-digit losses in 18 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -49.32% | A$0.37 | A$0.19 |
| 2025 | -70.99% | A$1.26 | A$0.37 |
| 2024 | -66.36% | A$3.74 | A$1.26 |
| 2023 | -24.14% | A$4.93 | A$3.74 |
| 2022 | -63.75% | A$13.60 | A$4.93 |
| 2021 | +300.00% | A$3.40 | A$13.60 |
| 2020 | +212.50% | A$1.09 | A$3.40 |
| 2019 | +77.78% | A$0.61 | A$1.09 |
| 2018 | +20.79% | A$0.51 | A$0.61 |
| 2017 | -20.86% | A$0.64 | A$0.51 |
| 2016 | +58.33% | A$0.40 | A$0.64 |
| 2015 | +20.00% | A$0.34 | A$0.40 |
| 2014 | -41.18% | A$0.57 | A$0.34 |
| 2013 | +54.55% | A$0.37 | A$0.57 |
| 2012 | -8.33% | A$0.40 | A$0.37 |
| 2011 | -78.18% | A$1.85 | A$0.40 |
| 2010 | -37.50% | A$2.97 | A$1.85 |
| 2009 | +3.53% | A$2.86 | A$2.97 |
| 2008 | -43.33% | A$5.05 | A$2.86 |
| 2007 | -40.99% | A$8.57 | A$5.05 |
| 2006 | +37.84% | A$6.21 | A$8.57 |
| 2005 | -30.19% | A$8.90 | A$6.21 |
| 2004 | +3.92% | A$8.57 | A$8.90 |
| 2003 | +64.52% | A$5.21 | A$8.57 |
| 2002 | +47.62% | A$3.53 | A$5.21 |
| 2001 | -77.05% | A$15.37 | A$3.53 |
| 2000 | -49.27% | A$30.30 | A$15.37 |
| 1999 | +110.49% | A$14.39 | A$30.30 |
| 1998 | -19.79% | A$17.94 | A$14.39 |
| 1997 | +50.00% | A$11.96 | A$17.94 |
| 1996 | -25.38% | A$16.03 | A$11.96 |
| 1995 | -12.24% | A$18.27 | A$16.03 |
| 1994 | -40.24% | A$30.57 | A$18.27 |
IMU Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Imugene Limited as an investment
Valuation
The forward P/E ratio is -1.4. The price-to-book ratio stands at 1.4. The price-to-sales ratio is 15.2.
Dividends
Imugene Limited does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
IMU has a beta of 2.48, indicating it is significantly more volatile than the overall market. The stock's 52-week range is A$0.18 to A$1.39, and it currently trades near its 52-week low.
Analyst Ratings
Based on 1 analyst opinion, IMU has a consensus "none" rating. The average price target of A$0.82 suggests 343.2% upside from current levels.
Frequently Asked Questions: IMU
What sector is IMU in? ▼
IMU operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has IMU performed historically? ▼
Over 33 years of trading history, IMU has posted gains in 14 years (42% of the time). The best year was 2021 with a +300.0% return. Past performance does not guarantee future results.
How can I invest in IMU? ▼
You can invest in IMU through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold IMU.
Does IMU pay dividends? ▼
Imugene Limited does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
What does Imugene Limited do? ▼
Imugene Limited is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Sydney, Australia.
What sector is IMU in? ▼
IMU operates in the Healthcare sector, specifically in the Biotechnology industry.
When did IMU go public? ▼
Imugene Limited went public in 1993, making it a 33-year-old public company as of 2026.
How much would A$1,000 invested in IMU 5 years ago be worth today? ▼
A A$1,000 investment in IMU five years ago would be worth approximately A$45 today, representing a -95.5% return.
How much would A$1,000 invested in IMU 10 years ago be worth today? ▼
A A$1,000 investment in IMU ten years ago would be worth approximately A$549 today, representing a -45.1% total return over the decade.
What is IMU's 3-year return? ▼
Over the past 3 years, IMU has returned -95.8%. A A$1,000 investment would have grown to A$42.
How much would A$1,000 invested in IMU at IPO be worth today? ▼
If you invested A$1,000 in IMU at its IPO in 1993, it would be worth approximately A$6 today, a -99.4% return over 33 years.
Does IMU pay dividends? ▼
No, Imugene Limited does not currently pay a dividend. The company reinvests its earnings into growth.
What is IMU's market cap? ▼
Imugene Limited has a market capitalization of A$60 million, classifying it as a micro-cap company.
Is IMU a buy, hold, or sell? ▼
Based on 1 opinion, IMU has a consensus "none" rating. The average price target is A$0.82.
Last updated: 3/15/2026